Glycine transport inhibitors in the treatment of schizophrenia

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

Glycine potentiates the NMDA response in cultured mouse brain neurons

Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,151 · see citing works

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Sreekumar, A., Poisson, L., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,238 · see citing works

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484 · see citing works

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035 · see citing works

Study of a New Schizophrenomimetic Drug—Sernyl

LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921 · see citing works

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869 · see citing works

Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man

Domino, E. F., Chodoff, P., & Corssen, G. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563279 · Cited by 753 · see citing works

Mismatch negativity in schizophrenia: a meta-analysis

Umbricht, D., & Krljes, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.002 · Cited by 742 · see citing works

Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits

Chatterton, J. E., Awobuluyi, M., Premkumar, L. S., Takahashi, H., Talantova, M. V., Shin, Y., Cui, J., Tu, S., Sevarino, K. A., Nakanishi, N., et al. (2002) · Nature · doi:10.1038/nature715 · Cited by 695 · see citing works

Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics

Malhotra, A. K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 681 · see citing works

NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

Malhotra, A. K. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00137-3 · Cited by 680 · see citing works

D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia

Tsai, G. E., Yang, P., Chang, Y., & Chong, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 676 · see citing works

Effects of Ketamine in Normal and Schizophrenic Volunteers

Lahti, A. C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674 · see citing works

Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.

Javitt, D. C., Steinschneider, M., Schroeder, C. E., & Arezzo, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11962 · Cited by 662 · see citing works

Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity

Yashiro, K., & Philpot, B. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.046 · Cited by 649 · see citing works

Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

Newcomer, J. W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00067-0 · Cited by 604 · see citing works

Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers

Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1139 · Cited by 583 · see citing works

D-serine added to antipsychotics for the treatment of schizophrenia

Tsai, G. E., Yang, P., Chung, L.-C., LANGE, N. D., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 572 · see citing works

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo

Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works

<i>N</i>-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494 · see citing works

Decreased Serum Levels of D-Serine in Patients With Schizophrenia

Hashimoto, K., Fukushima, T., Shimizu, E., Komatsu, N., Watanabe, H., 篠田, 直., Nakazato, M., Kumakiri, C., Okada, S.-I., Hasegawa, H., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.572 · Cited by 489 · see citing works

Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia

Heresco‐Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G. S., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487 · see citing works

Visual perception and its impairment in schizophrenia

Butler, P. D., Silverstein, S. M., & Dakin, S. C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.023 · Cited by 472 · see citing works

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

Øye, I., Paulsen, O., & Maurset, A. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11430-4 · Cited by 434 · see citing works

Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine: Support for Hyperglutamatergic Effects of<i>N-</i>methyl-D-aspartate Receptor Antagonists

Anand, A., Charney, D. S., Oren, D. A., Berman, R. M., Hu, X. S., Cappiello, A., & Krystal, J. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.270 · Cited by 426 · see citing works

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · see citing works

Zinc at glutamatergic synapses

Paoletti, P., Vergnano, A. M., Barbour, B., & Casado, M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.061 · Cited by 417 · see citing works

Modulation of N -methyl- d -aspartate receptor function by glycine transport

Bergeron, R., Meyer, T. M., Coyle, J. T., & Greene, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15730 · Cited by 412 · see citing works

Mismatch negativity: An index of a preattentive processing deficit in schizophrenia

Shelley, A. M., Ward, P. B., Catts, S. V., Michie, P. T., Andrews, S., & McConaghy, N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90126-7 · Cited by 411 · see citing works

Maldistribution of Interstitial Neurons in Prefrontal White Matter of the Brains of Schizophrenic Patients

Akbarian, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050061010 · Cited by 398 · see citing works

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

Heresco‐Levy, U., Javitt, D. C., Ebstein, R. P., Vass, Á., Lichtenberg, P., Bar, G., Catinari, S., & Ermilov, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.037 · Cited by 386 · see citing works

Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works

Early-stage visual processing and cortical amplification deficits in schizophrenia

Butler, P. D., Zemon, V., Schechter, I., Saperstein, A. M., Hoptman, M. J., Lim, K. O., Revheim, N., Silipo, G., & Javitt, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.5.495 · Cited by 362 · see citing works

Amelioration of negative symptoms in schizophrenia by glycine

Javitt, D. C., Zylberman, I., Zukin, S. R., Heresco‐Levy, U., & Lindenmayer, J. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1234 · Cited by 353 · see citing works

Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia

Adler, C. M., Malhotra, A. K., Elman, I., Goldberg, T. E., Egan, M. F., Pickar, D., & Breier, A. F. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1646 · Cited by 337 · see citing works

NMDA-receptor channel diversity in the developing cerebellum

Farrant, M., Feldmeyer, D., Takahashi, T., & Cull-Candy, S. G. (1994) · Nature · doi:10.1038/368335a0 · Cited by 323 · see citing works

A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia

Bendikov, I., Nadri, C., Amar, S., Panizzutti, R., DEMIRANDA, J., Wolosker, H., & Agam, G. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.10.010 · Cited by 323 · see citing works

Altered glutathione redox state in schizophrenia.

Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works

Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine: Implications for Glutamatergic and Dopaminergic Model Psychoses and Cognitive Function

Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.985 · Cited by 317 · see citing works

Impaired Mismatch Negativity Generation Reflects Widespread Dysfunction of Working Memory in Schizophrenia

Javitt, D. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950190032005 · Cited by 306 · see citing works

Effects of Ketamine on Thought Disorder, Working Memory, and Semantic Memory in Healthy Volunteers

Adler, C. M., Goldberg, T. E., Malhotra, A., Pickar, D., & Breier, A. F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00556-8 · Cited by 304 · see citing works

Molecular Mechanism of Neuronal Plasticity: Induction and Maintenance of Long-Term Potentiation in the Hippocampus

Miyamoto, E. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cpj06007x · Cited by 302 · see citing works

Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L. M., & Curran, H. V. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300342 · Cited by 277 · see citing works

Sarcosine or D-Serine Add-on Treatment for Acute Exacerbation of Schizophrenia

Lane, H., Chang, Y., Liu, Y., Chiu, C., & Tsai, G. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1196 · Cited by 271 · see citing works

PCP (Phencyclidine): Historical and Current Perspectives

Henderson, G. (1982) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(82)91253-6 · Cited by 263 · see citing works

Lamina-Specific Abnormalities of NMDA Receptor-Associated Postsynaptic Protein Transcripts in the Prefrontal Cortex in Schizophrenia and Bipolar Disorder

Beneyto, M., & Meador‐Woodruff, J. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301604 · Cited by 255 · see citing works

High dose D-serine in the treatment of schizophrenia

Kantrowitz, J. T., Malhotra, A. K., Cornblatt, B. A., Silipo, G. S., Balla, A., Suckow, R. F., D’Souza, C., Saksa, J. R., Woods, S. W., & Javitt, D. C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.012 · Cited by 253 · see citing works

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

Krystal, J. H., D’Souza, D. C., Karper, L. P., Bennett, A., Abi‐Dargham, A., Abi‐Saab, D., Cassello, K., Bowers, M. B., Vegso, S., Heninger, G. R., et al. (1999) · Psychopharmacology · doi:10.1007/s002130051049 · Cited by 243 · see citing works

Glycine Tranporter-1 Blockade Potentiates NMDA-Mediated Responses in Rat Prefrontal Cortical Neurons In Vitro and In Vivo

Chen, L., Muhlhauser, M. A., & Yang, C. R. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00680.2002 · Cited by 230 · see citing works

Motion perception in schizophrenia

Chen, Y., Palafox, G. P., Nakayama, K., Levy, D. L., Matthysse, S., & Holzman, P. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.149 · Cited by 225 · see citing works

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Depoortère, R., Dargazanli, G., Estenne‐Bouhtou, G., Coste, A., Lanneau, C., Desvignes, C., Poncelet, M., Héaulme, M., Santucci, V., Decobert, M., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300772 · Cited by 220 · see citing works

Obligatory Role of NR2A for Metaplasticity in Visual Cortex

Philpot, B. D., Cho, K. K. A., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.027 · Cited by 207 · see citing works

Multiple effects of spermine on N‐methyl‐D‐aspartic acid receptor responses of rat cultured hippocampal neurones.

Benveniste, M., & Mayer, M. L. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019627 · Cited by 202 · see citing works

Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid

Tóth, E., Sershen, H. W., Hashim, A. T., Vizi, E. S., & Lajtha, Á. (1992) · Neurochemical Research · doi:10.1007/bf00966669 · Cited by 194 · see citing works

Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia

Madeira, C., Freitas, M. E., Vargas-Lopes, C., Wolosker, H., & Panizzutti, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.002 · Cited by 190 · see citing works

Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype

Tsai, G. E., Ralph, R. J., Martina, M., Bergeron, R., Berger-Sweeney, J. E., Dunham, K. S., Jiang, Z., Caine, S. B., & Coyle, J. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402662101 · Cited by 190 · see citing works

The effect of varying stimulus intensity on NMDA-receptor activity in cat visual cortex

Fox, K., Sato, H., & Daw, N. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.64.5.1413 · Cited by 185 · see citing works

Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model

Labrie, V., Fukumura, R., Rastogi, A., Fick, L. J., Wang, W., Boutros, P. C., Kennedy, J. L., Semeralul, M. O., Lee, F. H., Baker, G. B., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp261 · Cited by 185 · see citing works

Control of NMDA Receptor Activation by a Glycine Transporter Co-Expressed in Xenopus Oocytes

Supplisson, S., & Bergman, C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04580.1997 · Cited by 184 · see citing works

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

Krystal, J. H., Karper, L. P., Bennett, A., D’Souza, D. C., Abi‐Dargham, A., Morrissey, K., Abi‐Saab, D., Bremner, J. D., Bowers, M. B., Suckow, R. F., et al. (1998) · Psychopharmacology · doi:10.1007/s002130050503 · Cited by 184 · see citing works

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

Krystal, J. H., Bennett, A., Abi‐Saab, D., Belger, A., Karper, L. P., D’Souza, D. C., Lipschitz, D. S., Abi‐Dargham, A., & Charney, D. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00097-9 · Cited by 183 · see citing works

Glycine Transporter I Inhibitor, N-methylglycine (Sarcosine), Added to Clozapine for the Treatment of Schizophrenia

Lane, H., Huang, C.-L., Wu, P.-L., Liu, Y., Chang, Y., Lin, P., Chen, P., & Tsai, G. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.005 · Cited by 179 · see citing works

d-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning

Duffy, S., Labrie, V., & Roder, J. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301486 · Cited by 173 · see citing works

d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats

Karasawa, J.-I., Hashimoto, K., & Chaki, S. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.033 · Cited by 172 · see citing works

ALX 5407: A Potent, Selective Inhibitor of the hGlyT1 Glycine Transporter

Atkinson, B. N., Bell, S. C., Vivo, M. D., Kowalski, L. R., Lechner, S. M., Ognyanov, V. I., Tham, C., Tsai, C., Jia, J., Ashton, D. J., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1414 · Cited by 169 · see citing works

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

Sumiyoshi, T., Yağcioğlu, A. E. A., Dai, J., Jayathilake, K., Lee, M. J., & Meltzer, H. Y. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003900 · Cited by 169 · see citing works

Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia

Buchanan, R. W., Freedman, R., Javitt, D. C., Abi‐Dargham, A., & Lieberman, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm083 · Cited by 169 · see citing works

Translating Glutamate: From Pathophysiology to Treatment

Javitt, D. C., Schoepp, D., Kalivas, P. W., Volkow, N. D., Zarate, C., Merchant, K., Bear, M. F., Umbricht, D., Hajos, M., Potter, W. Z., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002804 · Cited by 168 · see citing works

Glycine transporter type 1 blockade changes NMDA receptor‐mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels

Martina, M., Pyatkevich, Y., Halman, S., Lowe, J. A., III, Periyalwar, P., Schmidt, C. J., & Bergeron, R. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063321 · Cited by 167 · see citing works

Selective Cognitive Impairments Associated with NMDA Receptor Blockade in Humans

Rowland, L. M., Astur, R. S., Jung, R. E., Bustillo, J., Lauriello, J., & Yeo, R. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300642 · Cited by 167 · see citing works

Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study

Lane, H., Liu, Y., Huang, C., Chang, Y., Liau, C.-H., Perng, C., & Tsai, G. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.038 · Cited by 164 · see citing works

Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.

McBain, C. J., Kleckner, N. W., Wyrick, S. D., & Dingledine, R. J. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09633-6 · Cited by 164 · see citing works

Intracortical Mechanisms of Mismatch Negativity Dysfunction in Schizophrenia

Javitt, D. C. (2000) · Audiology and Neurotology · doi:10.1159/000013882 · Cited by 161 · see citing works

Synaptic dysfunction in Parkinson's disease

Bagetta, V., Ghiglieri, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380493 · Cited by 159 · see citing works

Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia

Lipina, T. V., Labrie, V., Weiner, I., & Roder, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2210-x · Cited by 159 · see citing works

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Lindsley, C. W., Shipe, W. D., Wolkenberg, S. E., Theberge, C. R., Williams, D., Jr., Sur, C., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057599 · Cited by 156 · see citing works

Deviance-elicited Changes in Event-related Potentials are Attenuated by Ketamine in Mice

Ehrlichman, R. S., Maxwell, C. R., Majumdar, S., & Siegel, S. J. (2008) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2008.20097 · Cited by 154 · see citing works

Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis

Heekeren, K., Daumann, J., Neukirch, A., Stock, C., Kawohl, W., Norra, C., Waberski, T. D., & Gouzoulis‐Mayfrank, E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1129-4 · Cited by 152 · see citing works

The Effects of a Sub-Anaesthetic Dose of Ketamine on Human Selective Attention

Oranje, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00118-9 · Cited by 147 · see citing works

Effect of ketamine on the neuromagnetic mismatch field in healthy humans

Kreitschmann‐Andermahr, I., Rosburg, T., Demme, U., Gaser, E., Nowak, H., & Sauer, H. (2001) · Cognitive Brain Research · doi:10.1016/s0926-6410(01)00043-x · Cited by 144 · see citing works

Comparison of Sernyl with Other Drugs

Rosenbaum, G. (1959) · A M A Archives of General Psychiatry · doi:10.1001/archpsyc.1959.03590060113013 · Cited by 141 · see citing works

Redox modulatory site of the NMDA receptor–channel complex: Regulation by oxidized glutathione

Sucher, N. J., & Lipton, S. A. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300316 · Cited by 140 · see citing works

Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers

Hetem, L. A. B., Danion, J., Diemunsch, P. A., & Brandt, C. (2000) · Psychopharmacology · doi:10.1007/s002130000511 · Cited by 139 · see citing works

Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action

Javitt, D. C., Duncan, L., Balla, A., & Sershen, H. W. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001552 · Cited by 137 · see citing works

Disruption of Glycine Transporter 1 Restricted to Forebrain Neurons Is Associated with a Procognitive and Antipsychotic Phenotypic Profile

Yee, B. K., Balic, E., Singer, P., Schwerdel, C., Grampp, T., Gabernet, L., Knuesel, I., Benke, D., Feldon, J., Möhler, H., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5120-05.2006 · Cited by 137 · see citing works

Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-(( S )-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia

Pinard, E., Alanine, A. I., Alberati, D., Bender, M., Borroni, E., Bourdeaux, P., Brom, V., Burner, S., Fischer, H., Hainzl, D., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100210p · Cited by 135 · see citing works

Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.

Javitt, D. C., & Zukin, S. R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11243-1 · Cited by 133 · see citing works

The G72/G30 Gene Complex and Cognitive Abnormalities in Schizophrenia

Goldberg, T. E., Straub, R. E., Callicott, J. H., Hariri, A. R., Mattay, V. S., Bigelow, L. B., Coppola, R., Egan, M. F., & Weinberger, D. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301049 · Cited by 133 · see citing works

Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats

Tikhonravov, D. L., Neuvonen, T., Pertovaara, A., Savioja, K., Ruusuvirta, T., Näätänen, R., & Carlson, S. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.006 · Cited by 131 · see citing works

Impaired visual recognition of biological motion in schizophrenia

Kim, J., Doop, M. L., Blake, R., & Park, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.006 · Cited by 131 · see citing works

Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia

Yang, C. R., & Svensson, K. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.004 · Cited by 129 · see citing works

Spatial Memory Deficits Induced by Perinatal Treatment of Rats with PCP and Reversal Effect of D-Serine

Andersen, J. D., & Pouzet, B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300394 · Cited by 126 · see citing works

NMDA Receptor Pharmacology: Perspectives from Molecular Biology

Lynch, D. R., & Guttmann, R. P. (2001) · Current Drug Targets · doi:10.2174/1389450013348434 · Cited by 123 · see citing works

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments

Schmidt, A., Bachmann, R., Kometer, M., Csomor, P. A., Stephan, K. E., Seifritz, E., & Vollenweider, F. X. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.261 · Cited by 121 · see citing works

D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia

Contreras, P. C. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90015-j · Cited by 121 · see citing works

Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis

Heresco‐Levy, U., & Javitt, D. C. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00129-4 · Cited by 120 · see citing works

Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers*

Hartvig, P., Valtysson, J., Lindner, K., Kristensen, J. D., Karlsten, R., Gustafsson, L. L., Persson, J., Svensson, J. O., Øye, I., Antoni, G., et al. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90194-9 · Cited by 120 · see citing works

A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia

Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.025 · Cited by 112 · see citing works

THE GLYCINE REUPTAKE INHIBITOR ORG 25935 DECREASES ETHANOL INTAKE AND PREFERENCE IN MALE WISTAR RATS

Molander, A., Lidö, H. H., Löf, E., Ericson, M., & Söderpalm, B. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl085 · Cited by 109 · see citing works

Neurotransmitter receptors mediating excitatory input to cells in the cat lateral geniculate nucleus. I. Lagged cells

Heggelund, P., & Hartveit, E. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.63.6.1347 · Cited by 109 · see citing works

Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal–lesioned rats: reversal by glycine and a glycine transporter inhibitor

Pen, G. L., Kew, J. N. C., Alberati, D., Borroni, E., Heitz, M., & Moreau, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00374-3 · Cited by 108 · see citing works

Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward

Braida, D., Limonta, V., Capurro, V., Fadda, P., Rubino, T., Mascia, P., Zani, A. D., Gori, E., Fratta, W., Parolaro, D., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.020 · Cited by 107 · see citing works

Relation of Plasma Glycine, Serine, and Homocysteine Levels to Schizophrenia Symptoms and Medication Type

Neeman, G., Blanaru, M., Bloch, B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1738 · Cited by 107 · see citing works

Low dose ketamine increases prepulse inhibition in healthy men

Abel, K. M., Allin, M. P. G., Hemsley, D. R., & Geyer, M. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00073-x · Cited by 106 · see citing works

New pharmacologic horizons in the treatment of Parkinson disease

Bonuccelli, U., & Dotto, P. D. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s30 · Cited by 102 · see citing works

Glycine Therapy of Schizophrenia

Waziri, R. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90093-5 · Cited by 100 · see citing works

Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors

Javitt, D. C., Balla, A., Sershen, H. W., & Lajtha, Á. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00237-6 · Cited by 99 · see citing works

Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists

Javitt, D., Balla, A., Burch, S., Suckow, R., Xie, S., & Sershen, H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300313 · Cited by 98 · see citing works

The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study

Hársing, L. G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01078-x · Cited by 97 · see citing works

Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats

de Bruin, N. M. W. J., Ellenbroek, B. A., Cools, A. R., Coenen, A. M. L., & van Luijtelaar, E. L. J. M. (1999) · Psychopharmacology · doi:10.1007/s002130050856 · Cited by 96 · see citing works

Discovery and SAR of Org 24598—A Selective Glycine Uptake Inhibitor

Brown, A. R., Carlyle, I., Clark, J., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00355-9 · Cited by 95 · see citing works

Antagonism of phencyclidine-induced hyperactivity by glycine in mice

Tóth, E., & Lajtha, Á. (1986) · Neurochemical Research · doi:10.1007/bf00965013 · Cited by 94 · see citing works

Glutamatergic Modulation of Auditory Information Processing in the Human Brain

Gunduz-Bruce, H., Reinhart, R. M. G., Roach, B. J., Gueorguieva, R., Oliver, S., D'Souza, D. C., Ford, J. M., Krystal, J. H., & Mathalon, D. H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.031 · Cited by 93 · see citing works

Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers

Mexal, S., Frank, M., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., & Leonard, S. S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.06.006 · Cited by 93 · see citing works

N[3‐(4′‐fluorophenyl)‐3‐(4′‐phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport

Aubrey, K. R., & Vandenberg, R. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704381 · Cited by 92 · see citing works

Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in micePreprint

Labrie, V., Duffy, S. N., Wang, W., Barger, S. W., Baker, G. B., & Roder, J. (2008) · Learning & Memory · doi:10.1101/lm.1112209 · Cited by 89 · see citing works

Does Ketamine-Mediated N-methyl-D-aspartate Receptor Antagonism Cause Schizophrenia-like Oculomotor Abnormalities?

Radant, A. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00030-x · Cited by 89 · see citing works

PCP (phencyclidine), historical and current perspectives

Domino, E. F. (1981) · Medical Entomology and Zoology · Cited by 88 · see citing works

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆

Boulay, D., Pichat, P., Dargazanli, G., Estenne‐Bouhtou, G., Terranova, J.-P., Rogacki, N., Stemmelin, J., COSTE, A., Lanneau, C., & Desvignes, C. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.06.009 · Cited by 87 · see citing works

The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers

Parwani, A., Weiler, M. A., Blaxton, T. A., Warfel, D. T., Hardin, M. G., Frey, K., & Lahti, A. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0177-2 · Cited by 87 · see citing works

Neuropsychopharmacology

Bradshaw, C. M. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199234110.003.025 · Cited by 87 · see citing works

Serum sarcosine is not a marker for prostate cancer

Struys, E. A., Heijboer, A. C., van Moorselaar, J., et al. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.009270 · Cited by 85 · see citing works

Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients

Javitt, D. C. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214340.14131.bd · Cited by 85 · see citing works

Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas

Perry, K. W., Falcone, J. F., Fell, M. J., Ryder, J. W., Yu, H. Y., Love, P. L., Katner, J., Gordon, K. D., Wade, M. R., Man, T., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.016 · Cited by 84 · see citing works

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

Black, M. D., Varty, G. B., Arad, M., Barak, S., Levie, A. D., Boulay, D., Pichat, P., Griebel, G., & Weiner, I. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1289-2 · Cited by 83 · see citing works

d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats

Shimazaki, T., Kaku, A., & Chaki, S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1794-y · Cited by 81 · see citing works

Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys

Linn, G. S., Negi, S., Gerum, S. V., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1533-8 · Cited by 81 · see citing works

Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults

Greenberg, W. M., Benedict, M. M., Doerfer, J., Perrin, M., Panek, L., Cleveland, W. L., & Javitt, D. C. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.007 · Cited by 80 · see citing works

NMDA and non-NMDA receptors mediate visual responses of neurons in the cat's lateral geniculate nucleus

Kwon, Y. H., Esguerra, M., & Sur, M. (1991) · Journal of Neurophysiology · doi:10.1152/jn.1991.66.2.414 · Cited by 79 · see citing works

Coagonist Release Modulates NMDA Receptor Subtype Contributions at Synaptic Inputs to Retinal Ganglion Cells

Kalbaugh, T. L., Zhang, J., & Diamond, J. S. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4240-08.2009 · Cited by 76 · see citing works

p75NTR immunoreactivity in the rat dentate gyrus is mostly within presynaptic profiles but is also found in some astrocytic and postsynaptic profiles

Dougherty, K. D., & Milner, T. A. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990428)407:1 · Cited by 76 · see citing works

Subdissociative Dose Ketamine Produces a Deficit in Manipulation but not Maintenance of the Contents of Working Memory

Honey, R. A. E., Turner, D. C., Honey, G. D., Sharar, S. R., Kumaran, D., Pomarol‐Clotet, E., McKenna, P. J., Sahakian, B. J., Robbins, T. W., & Fletcher, P. C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300272 · Cited by 75 · see citing works

Reversal of Phencyclidine-Induced Hyperactivity by Glycine and the Glycine Uptake Inhibitor Glycyldodecylamide

Javitt, D. C. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00047-x · Cited by 74 · see citing works

Glycine transporters and synaptic function

Zafra, F., & Giménez, C. (2008) · IUBMB Life · doi:10.1002/iub.128 · Cited by 73 · see citing works

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine

Hashimoto, K., Fujita, Y., Ishima, T., Chaki, S., & Iyo, M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.009 · Cited by 73 · see citing works

The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

Wood, P. L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00288-h · Cited by 72 · see citing works

Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia

Gravina, P., Spoletini, I., Masini, S., Valentini, A., Vanni, D., Paladini, E., Bossù, P., Caltagirone, C., Federici, G., Spalletta, G., et al. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.008 · Cited by 71 · see citing works

Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse

Javitt, D. C., & Frusciante, M. J. (1997) · Psychopharmacology · doi:10.1007/s002130050168 · Cited by 70 · see citing works

Substance use disorders and schizophrenia: A question of shared glutamatergic mechanisms

Coyle, J. T. (2006) · Neurotoxicity Research · doi:10.1007/bf03033359 · Cited by 69 · see citing works

G72/G30 Genes and Schizophrenia: A Systematic Meta-analysis of Association Studies

Li, D., & He, L. (2006) · Genetics · doi:10.1534/genetics.106.061796 · Cited by 67 · see citing works

Inhibitors of GlyT1 Affect Glycine Transport via Discrete Binding Sites

Mezler, M., Hornberger, W., Mueller, R., Schmidt, M. U., Amberg, W., Braje, W. M., Ochse, M., Schoemaker, H., & Behl, B. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049312 · Cited by 62 · see citing works

Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses

Tóth, E., & Lajtha, Á. (1981) · Neurochemical Research · doi:10.1007/bf00964352 · Cited by 61 · see citing works

Effects of the NMDA Antagonist Ketamine on Task-Switching Performance: Evidence for Specific Impairments of Executive Control

Stoet, G., & Snyder, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300930 · Cited by 61 · see citing works

Evidence for association and epistasis at the DAOA/G30 and D ‐amino acid oxidase loci in an Irish schizophrenia sample

Corvin, A. P., McGhee, K. A., Murphy, K., Donohoe, G. J., Nangle, J. M., Schwaiger, S., KENNY, N. W., Clarke, S., Meagher, D. J., Quinn, J. P., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30452 · Cited by 59 · see citing works

Glycine Transporter 1 Inhibitors and Modulation of NMDA Receptor-Mediated Excitatory Neurotransmission

Sur, C., & Kinney, G. G. (2007) · Current Drug Targets · doi:10.2174/138945007780618535 · Cited by 59 · see citing works

The Glycine Reuptake Inhibitor Org 25935 Interacts With Basal and Ethanol‐Induced Dopamine Release in Rat Nucleus Accumbens

Lidö, H. H., Stomberg, R., Fagerberg, A., Ericson, M., & Söderpalm, B. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00938.x · Cited by 59 · see citing works

Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter‐1 (GlyT1)

Manahan‐Vaughan, D., Wildförster, V., & Thomsen, C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06433.x · Cited by 58 · see citing works

Switch and maintenance of task set in schizophrenia

Kieffaber, P. D., Kappenman, E. S., Bodkins, M., Shekhar, A., O’Donnell, B. F., & Hetrick, W. P. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.01.022 · Cited by 58 · see citing works

D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease

Gelfin, E., Kaufman, Y., Korn‐Lubetzki, I., Bloch, B., Kremer, I., Javitt, D. C., & Heresco‐Levy, U. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001015 · Cited by 57 · see citing works

Specific Roles of NMDA and AMPA Receptors in Direction-Selective and Spatial Phase-Selective Responses in Visual Cortex

Rivadulla, C., Sharma, J., & Sur, M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01710.2001 · Cited by 55 · see citing works

Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state

Abel, K. M., Allin, M. P. G., Kucharska‐Pietura, K., Andrew, C., Williams, S., David, A. S., & Phillips, M. L. (2002) · Human Brain Mapping · doi:10.1002/hbm.10064 · Cited by 55 · see citing works

Transient expression of the NR2C subunit of the NMDA receptor in developing rat brain

Pollard, H., Khrestchatisky, M., Moreau, J., et al. (1993) · Neuroreport · doi:10.1097/00001756-199304000-00018 · Cited by 53 · see citing works

The Analgesic and Anesthetic Effect of lN-(l-Phenylcyclohexyl) Piperidine $$ HCl on the Monkey

CHEN, G. M., & Weston, J. K. (1960) · Anesthesia & Analgesia · doi:10.1213/00000539-196003000-00004 · Cited by 52 · see citing works

The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice

Singer, P., Feldon, J., & Yee, B. K. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1286-5 · Cited by 51 · see citing works

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

Hashimoto, K., & r (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049598 · Cited by 51 · see citing works

Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia

Shinkai, T., Luca, V. D., Hwang, R., Müller, D. J., Lanktree, M. B., Zai, G. C., Shaikh, S. A., Wong, G. W. H., Sicard, T., Potapova, N., et al. (2007) · NeuroMolecular Medicine · doi:10.1007/bf02685890 · Cited by 50 · see citing works

Glycine transporter inhibition reverses ketamine-induced working memory deficits

Roberts, B. M., Shaffer, C. L., Seymour, P. A., Schmidt, C. J., Williams, G. V., & Castner, S. A. (2010) · Neuroreport · doi:10.1097/wnr.0b013e3283381a4e · Cited by 50 · see citing works

Modulation of Striatal Dopamine Release by Glycine Transport Inhibitors

Javitt, D., Hashim, A., & Sershen, H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300589 · Cited by 48 · see citing works

Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia

Burnet, P. W. J., Hutchinson, L. J., VONHESLING, M., Gilbert, E. M., Brandon, N. J., Rutter, A. R., Hutson, P. H., & Harrison, P. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.009 · Cited by 45 · see citing works

Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn 2+ and NR1 antagonist

Madry, C., Betz, H., Geiger, J. R. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805624105 · Cited by 42 · see citing works

Sarcosine Therapy for Obsessive Compulsive Disorder

Wu, P.-L., Tang, H., Lane, H., Tsai, C., & Tsai, G. E. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182189878 · Cited by 40 · see citing works

Design of potent GlyT1 inhibitors: in vitro and in vivo profiles.

Bridges, T. M., Williams, R. D., & Lindsley, C. W. (2008) · PubMed · Cited by 37 · see citing works

Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors

Wolkenberg, S. E., & Sur, C. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790410974 · Cited by 36 · see citing works

Effects of Different Subanesthetic Doses of (S)-Ketamine on Neuropsychology, Psychopathology, and State of Consciousness in Man

Passie, T., Karst, M., Wiese, B., Emrich, H. M., & Schneider, U. (2005) · Neuropsychobiology · doi:10.1159/000085724 · Cited by 35 · see citing works

The synthesis and preclinical evaluation in rhesus monkey of [18F]MK‐6577 and [11C]CMPyPB glycine transporter 1 positron emission tomography radiotracers

Hamill, T. G., Eng, W., Jennings, A. S. R., Lewis, R. T., Thomas, S., Wood, S., Street, L. J., Wisnoski, D. D., Wolkenberg, S. E., Lindsley, C. W., et al. (2010) · Synapse · doi:10.1002/syn.20842 · Cited by 34 · see citing works

Transport Is the Primary Determinant of Glycine Content in Retinal Neurons

Pow, D. V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062628.x · Cited by 34 · see citing works

Behavioral effects of chronic phencyclidine in monkeys

Linn, G. S., O’Keeffe, R. T., Schroeder, C. E., et al. (1999) · Neuroreport · doi:10.1097/00001756-199909090-00017 · Cited by 34 · see citing works

Characterization of the Interactive Effects of Glycine and D-Cycloserine in Men: Further Evidence for Enhanced NMDA Receptor Function Associated with Human Alcohol Dependence

Krystal, J. H., Petrakis, I. L., Limoncelli, D., Krasnicki, S., Trevisan, L. A., Pittman, B. P., & D’Souza, D. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.203 · Cited by 33 · see citing works

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9with schizophrenia

Deng, X., Sagata, N., Takeuchi, N., Tanaka, M., Ninomiya, H., Iwata, N., Ozaki, N., Shibata, H., & Fukumaki, Y. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-58 · Cited by 32 · see citing works

Schizophrenia Patients Show Task Switching Deficits Consistent With N-Methyl-D-Aspartate System Dysfunction But Not Global Executive Deficits: Implications for Pathophysiology of Executive Dysfunction in Schizophrenia

Wylie, G. R., Clark, E., Butler, P. D., & Javitt, D. C. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn119 · Cited by 30 · see citing works

N-Methyl-d-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process

Ahn, K.-H., Youn, T., Cho, S. S., Ha, T. H., Ha, K., Kim, M., & Kwon, J. S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00159-3 · Cited by 28 · see citing works

Sustained saturating level of glycine induces changes in NR2B‐containing‐NMDA receptor localization in the CA1 region of the hippocampus

Imamura, Y., Ma, C., Pabba, M., & Bergeron, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05324.x · Cited by 27 · see citing works

A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies

Zeng, Z., O’Brien, J. A., Lemaire, W., O'Malley, S. S., Miller, P. J., Zhao, Z., Wallace, M. A., Raab, C. E., Lindsley, C. W., Sur, C., et al. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.12.002 · Cited by 27 · see citing works

Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone

Nagy, K. E., Markó, B., Zsilla, G., Mátyus, P., Pallagi, K., Szabo, G., Jurányi, Z., Barkóczy, J., Lévay, G. I., & Hársing, L. G. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0241-0 · Cited by 26 · see citing works

Deletion of glycine transporter 1 (GlyT1) in forebrain neurons facilitates reversal learning: Enhanced cognitive adaptability?

Singer, P., Boison, D., Möhler, H., Feldon, J., & Yee, B. K. (2009) · Behavioral Neuroscience · doi:10.1037/a0016676 · Cited by 24 · see citing works

Proprioception and schizophrenia: A replication study with nonschizophrenic patient controls.

Ritzler, B. A. (1977) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.86.5.501 · Cited by 24 · see citing works

Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics

Bennett, S., & Gronier, B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.015 · Cited by 23 · see citing works

The glycine transporter 1 gene (GLYT1) is associated with methamphetamine‐use disorder

Morita, Y., Ujike, H., Tanaka, Y., Kishimoto, M., Okahisa, Y., Kotaka, T., Harano, M., Inada, T., Komiyama, T., Hori, T., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30565 · Cited by 23 · see citing works

Discovery of GlyT1 inhibitors with improved pharmacokinetic properties

Wolkenberg, S. E., Zhao, Z., Wisnoski, D. D., Leister, W., O'Brien, J. L., Lemaire, W., Williams, D. L., Jacobson, M. A., Sur, C., Kinney, G. G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.015 · Cited by 22 · see citing works

Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands

Herdon, H. J., Roberts, J. C., Coulton, S., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.023 · Cited by 21 · see citing works

SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats

Nishikawa, H., Inoue, T., Izumi, T., Nakagawa, S., & Koyama, T. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833d419d · Cited by 20 · see citing works

The Role of GlycineB Binding Site and Glycine Transporter (GlyT1) in the Regulation of [3H]GABA and [3H]Glycine Release in the Rat Brain

Hársing, L. G., Sólyom, S., & Salamon, C. (2001) · Neurochemical Research · doi:10.1023/a:1012328300037 · Cited by 18 · see citing works

Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential

Alberati, D., Moreau, J., Mory, R., Pinard, E., & Wettstein, J. G. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.07.016 · Cited by 18 · see citing works

An investigation of drug induced sensory disturbances

Morgenstern, F., Beech, H. R., & Davies, B. M. (1962) · Psychopharmacology · doi:10.1007/bf00412105 · Cited by 18 · see citing works

The synaptic and nonsynaptic glycine transporter type-1 inhibitors Org-24461 and NFPS alter single neuron firing rate in the rat dorsal raphe nucleus

Papp, A., Jurányi, Z., Nagymajtényi, L., et al. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.030 · Cited by 16 · see citing works

Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors

Pinard, E., Alberati, D., Bender, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.124 · Cited by 16 · see citing works

Proprioception and schizophrenia: A replication study with nonschizophrenic patient controls.

Ritzler, B. A. (1977) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.86.5.501 · Cited by 16 · see citing works

New cyclic tetrapeptides from Nonomuraea sp. TA-0426 that inhibit glycine transporter type 1 (GlyT1)

Terui, Y., Chu, Y., Li, J., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.104 · Cited by 14 · see citing works

Changes in glycine and leucine transport during red cell maturation in the rat

Felipe, A., Viñas, O., & Remesar, X. (1990) · Bioscience Reports · doi:10.1007/bf01116580 · Cited by 14 · see citing works

An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter

Lowe, J. A., III, DeNinno, S. L., Drozda, S. E., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.071 · Cited by 11 · see citing works

Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex.

Javitt, D. C., Frusciante, M. J., & Zukin, S. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22395-3 · Cited by 7 · see citing works

Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1

Varnes, J. G., Forst, J. M., Hoerter, T. N., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.085 · Cited by 6 · see citing works

Blood Glutathione and Eosinophil Levels and Hospital Adjustment Scale in Chronic Schizophrenia

Altschule, M. D. (1959) · A M A Archives of General Psychiatry · doi:10.1001/archpsyc.1959.03590040028002 · Cited by 5 · see citing works

Na+-coupled glycine transport in reticulocyte vesicles of distinct sidedness: Stoichiometry and symmetry

Weigensberg, A. M., & Blostein, R. E. (1985) · The Journal of Membrane Biology · doi:10.1007/bf01871608 · Cited by 5 · see citing works

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works

Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders

Venero, C. (2015) · Cognitive Enhancement · doi:10.1016/b978-0-12-417042-1.00010-3 · Cited by 4 · see citing works

Light-evoked release of glycine from the retina

Ehinger, B., & LINDBERG, B. (1974) · Nature · doi:10.1038/251727a0 · Cited by 38 · see citing works

P.3.c.023 Glycine plasma levels are not a useful predictor of recovery in patients treated with glycine and neuroleptics

Strzelecki, D., & Rabe‐Jabłońska, J. (2010) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(10)70693-3 · Cited by 1 · see citing works

Electrolytes in solutions of amino acids. Part III.—The silver complexes of glycine, alanine and glycyl-glycine

Monk, C. B. (1951) · Transactions of the Faraday Society · doi:10.1039/tf9514700292 · Cited by 33 · see citing works

Metabolism of Glycine by the Completely Isolated Mammalian Heart Investigated with Garboxyl-Labeled Glycine.

Lorber, V., & Olsen, N. S. (1946) · Experimental Biology and Medicine · doi:10.3181/00379727-61-15282 · Cited by 8 · see citing works

Structures of three glycine-bridged polymeric complexes: [Mn(glycine)(H2O)2Cl2], [Co(glycine)(H2O)2Cl2] and [Co(glycine)(H2O)4](NO3)2

Clegg, W., Lacy, O. M., & STRAUGHAN, B. P. (1987) · Acta Crystallographica Section C Crystal Structure Communications · doi:10.1107/s0108270187094058 · Cited by 10 · see citing works